Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adela Madrid-Paredes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmaceutics|August 26, 2022
-Omic Approaches and Treatment Response in Rheumatoid ArthritisAdela Madrid-Paredes, Javier Martín, Ana Márquez
Pharmacogenomics|August 11, 2015
De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancerAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Breast Cancer Research and Treatment|September 25, 2015
Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancerAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Surgical Oncology|November 9, 2017
ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysisAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Pharmacological Research|May 4, 2016
ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patientsAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Pathology, Research and Practice|March 5, 2020
Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosisAdela Madrid-Paredes, Miguel Ángel Casado-Combreras, Cristina Pérez-Ramírez, et al.
Journal of Health, Population, and Nutrition|May 22, 2023
Impact of nutritional and educational support on home enteral nutritionAdela Madrid-Paredes, Socorro Leyva-Martínez, Verónica Ávila-Rubio, et al.
The Lancet. Rheumatology|May 11, 2024
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association studyGonzalo Borrego-Yaniz, Lourdes Ortiz-Fernández, Adela Madrid-Paredes, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutics|August 26, 2022
-Omic Approaches and Treatment Response in Rheumatoid ArthritisAdela Madrid-Paredes, Javier Martín, Ana Márquez
Pharmacogenomics|August 11, 2015
De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancerAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Breast Cancer Research and Treatment|September 25, 2015
Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancerAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Surgical Oncology|November 9, 2017
ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysisAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Pharmacological Research|May 4, 2016
ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patientsAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Pathology, Research and Practice|March 5, 2020
Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosisAdela Madrid-Paredes, Miguel Ángel Casado-Combreras, Cristina Pérez-Ramírez, et al.
Journal of Health, Population, and Nutrition|May 22, 2023
Impact of nutritional and educational support on home enteral nutritionAdela Madrid-Paredes, Socorro Leyva-Martínez, Verónica Ávila-Rubio, et al.
The Lancet. Rheumatology|May 11, 2024
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association studyGonzalo Borrego-Yaniz, Lourdes Ortiz-Fernández, Adela Madrid-Paredes, et al.
Pageof 1